SCHEMBL9893215

SCHEMBL9893215

CC(C)(C)OC(=O)N1CCC[C@@H]1C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.50
▸ EPHX2 P34913 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ UCHL1 P09936 4/20 0.47
▸ KLK7 P49862 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ GLA P06280 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ SCN4A P35499 1/20 0.43
▸ USP30 Q70CQ3 1/20 0.43
▸ SCN5A Q14524 1/20 0.41
▸ SCN3A Q9NY46 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL357242 1.00 HSD17B10 (0.50) HSD17B10EPHX2NPC1UCHL1KLK7
SCHEMBL4959104 1.00 HSD17B10 (0.50) HSD17B10EPHX2NPC1UCHL1KLK7
SCHEMBL10347006 0.96 HSD17B10 (0.46) HSD17B10EPHX2NPC1UCHL1KLK7
SCHEMBL29484187 0.95 HSD17B10 (0.52) HSD17B10EPHX2NPC1UCHL1KLK7
SCHEMBL6176907 0.90 HSD17B10 (0.44) HSD17B10EPHX2NPC1UCHL1KLK7
SCHEMBL18206674 0.87 HSD17B10 (0.44) HSD17B10EPHX2NPC1UCHL1KLK7
SCHEMBL18206675 0.87 HSD17B10 (0.44) HSD17B10EPHX2NPC1UCHL1KLK7
SCHEMBL19658258 0.84 HSD17B10 (0.42) HSD17B10EPHX2NPC1UCHL1KLK7
SCHEMBL21049847 0.84 HSD17B10 (0.42) HSD17B10EPHX2NPC1UCHL1KLK7
SCHEMBL19658381 0.84 HSD17B10 (0.42) HSD17B10EPHX2NPC1UCHL1KLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4686470-A1 MACROCYCLIC PEPTIDOMIMETICS AS ANTIVIRAL AGENTS Ospedale San Raffaele S.r.l. (IT) 2026-02-04 — — EP disclosed
EP-4425181-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTE Bertis Inc (KR) 2024-09-04 — — EP disclosed
US-20240011979-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTES BERTIS INC. (KR) 2024-01-11 — — US disclosed
CN-116829949-A Compositions for detecting or measuring analytes 伯蒂斯有限公司 2023-09-29 — — CN disclosed
WO-2023075435-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTE 주식회사 베르티스 2023-05-04 — — WO disclosed
US-20220283131-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTES BERTIS CO., LTD. (KR) 2022-09-08 — — US disclosed
WO-2022050529-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTE ㈜베르티스 2022-03-10 — — WO disclosed
CN-102540713-A Resin composition for laser engraving, relief printing plate precursor for laser engraving and process for producing same, and process for making relief printing plate FUJIFILM CORP 2012-07-04 — — CN disclosed
US-20120146264-A1 RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND PROCESS FOR MAKING RELIEF PRINTING PLATE FUJIFILM CORPORATION (JP) 2012-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120146264-A1 RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND PROCESS FOR MAKING RELIEF PRINTING PLATE EIF3L, EIF2B1, EIF2B5 HSD17B10 2408/4885EPHX2 1157/4885NPC1 4767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback